Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Breast Cancer Research and Treatment|December 11, 2014
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancerJennifer R Bean, Sarah R Hosford, Lynn K Symonds, et al.Urology|January 15, 2026
Reducing opioid utilization after ureteroscopy without compromising patient outcomes in a statewide quality improvement collaborativeWilson Sui, Suprita Krishna, Russell Becker, et al.The Journal of Urology|May 17, 2026
Predictors of Medication Cessation After Benign Prostatic Hyperplasia ProceduresMichael Uy, John Michael DiBianco, Sabry Mansour, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.The Journal of Urology|March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the BladderGuarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.Journal of the National Cancer Institute|July 10, 2026
Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome predictionMatthew R Cooperberg, Kevin Shee, Janet E Cowan, et al.Research Square|November 24, 2025
Integrated AAV optimization enables efficient gene delivery to kidney in murine and human tissueFernando Gomez Garcia, Miriam Rivera Moreno, Shashank Chetty, et al.Nature|July 6, 2012
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionRavid Straussman, Teppei Morikawa, Kevin Shee, et al.Breast Cancer Research and Treatment|June 21, 2020
Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancerMary D Chamberlin, Jason D Wells, Kevin Shee, et al.Pageof 14